Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05999968
What this trial is testing

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Who this might be right for
Prostatic Neoplasms
Eli Lilly and Company 10
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT01240629
What this trial is testing

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 43
Post-approval studies (Phase 4)Looking for participantsNCT05919329
What this trial is testing

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Who this might be right for
Castration Resistant Prostate CancerCastration Sensitive Prostate CancerProstate Adenocarcinoma
OHSU Knight Cancer Institute 80
Not applicableEnded earlyNCT05208229
What this trial is testing

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 2
Large-scale testing (Phase 3)Study completedNCT01707966
What this trial is testing

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 47
Early research (Phase 1)Looking for participantsNCT07145177
What this trial is testing

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Looking for participantsNCT04038502
What this trial is testing

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations
VA Office of Research and Development 100
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 219
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Not applicableWithdrawnNCT02867345
What this trial is testing

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Peking University
Large-scale testing (Phase 3)Looking for participantsNCT06925737
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Who this might be right for
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC 1,440
Large-scale testing (Phase 3)Study completedNCT03834493
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,244
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT07553988
What this trial is testing

A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
R-Pharm International, LLC 120
Testing effectiveness (Phase 2)WithdrawnNCT06527690
What this trial is testing

Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastrate Resistant Prostate CancerHomologous Recombination Deficiency
Latin American Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Early research (Phase 1)Enrolling By InvitationNCT07583160
What this trial is testing

YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer PatientsCastration-Resistant Prostate Cancer (CRPC)Prostate Neoplasms
Changhai Hospital 18
Not applicableStudy completedNCT02269982
What this trial is testing

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Who this might be right for
Prostate Cancer
Duke University 120
Early research (Phase 1)Looking for participantsNCT07277270
What this trial is testing

GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 83
Next Page